Phase II results are over a year old. They should have been able to start Phase III by now. I like the story and the price for Prolor, but this length of time with nothing happening, or even announced, worries me. Have I missed something, or are they just burning cash doing nothing?
It probably takes a long time for other drug companies to look at alternative (presumably simpler and safer) long-acting method. Today's saga of "Novo Nordisk shares fall after FDA raises heart concerns with long-acting insulin" may hasten other drug companies besides MRK to try PBTH's CTP methods of making long-acting proteins.